Due to health issues, this site is no longer maintained and will be shut down shortly. |
We are a global, commercial-stage biopharmaceutical company dedicated to commercializing and developing novel therapeutics to treat patients suffering from serious and life-threatening rare diseases.This company has ADRs that trade in the U.S. as the symbol AMYT.
143.00 GBP
As of 01/10/2022
2022 © Stock Market MBA, Inc.